REFERENCES
1. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016, 8 : 595-608.
2. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011, 108 : 5819-5824.
3. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006, 75 : 333-66.
4. Cohen SIA, Cukalevski R, Michaels TCT, Šarić A, Törnquist M, Vendruscolo M, Dobson CM, Buell AK, Knowles TPJ, Linse S. Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide. Nat Chem. 2018, 10 : 523-531.
5. Cawood, E.E.; Karamanos, T.K.; Wilson, A.J.; Radford, S.E. Visualizing and Trapping Transient Oligomers in Amyloid Assembly Pathways. Biophys Chem. 2021, 268 : 106505.
6. Nasica-Labouze J, Nguyen PH, Sterpone F, Berthoumieu O, Buchete NV, Coté S, De Simone A, Doig AJ, Faller P, Garcia A., et al. Amyloid β protein and Alzheimer’s disease: When computer simulations complement experimental studies. Chem. Rev. 2015, 115 : 3518-3563.
7. Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, Dominguez L, Shea JE, Dokholyan NV, De Simone A., et al. Amyloid oligomers: A joint experimental/computational perspective on Alzheimer’s disease, Parkinson’s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem Rev. 2021, 121 : 2545-2647.
8. Jeon J, Blake Wilson C, Yau WM, Thurber KR, Tycko R. Time-resolved solid state NMR of biomolecular processes with millisecond time resolution. J Magn Reson. 2022, 342 : 107285.
9. Strodel B. Amyloid aggregation simulations: challenges, advances and perspectives. Curr Opin Struct Biol. 2021, 67 : 145-152.
10. Nguyen P, Derreumaux P. Understanding amyloid fibril nucleation and Aβ oligomer/drug interactions from computer simulations. Acc Chem Res. 2014, 47 : 603-611.
11. Barz B, Liao Q, Strodel B. Pathways of amyloid-β aggregation depend on oligomer shape. J Am Chem Soc. 2018, 140 : 319-327.
12. Robustelli P, Piana S, Shaw DE. Developing a molecular dynamics force field for both folded and disordered protein states. Proc Natl Acad Sci U S A. 2018, 115 : E4758-E4766.
13. Nguyen TH, Nguyen PH, Ngo ST, Derreumaux P. Effect of cholesterol molecules on Aβ1-42 wild-type and mutants trimers. Molecules.2022, 27 : 1395.
14. Chakravorty A, McCalpin SD, Sahoo BR, Ramamoorthy A, Brooks C.L. 3rd. Free gangliosides can alter amyloid-β aggregation. J Phys Chem Lett. 2022, 13 : 9303-9308.
15. Boopathi S, Garduño-Juárez R. Calcium inhibits penetration of Alzheimer’s Aβ1 -42monomers into the membrane. Proteins. 2022, 90 : 2124-2143.
16. Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A.2009, 106 : 14745-14750.
17. Roche J, Shen Y, Lee JH, Ying J, Bax A. Monomeric Aβ1−40 and Aβ1−42 peptides in solution adopt very similar Ramachandran map distributions that closely resemble random coil. Biochemistry 2016,55 : 762−775.
18. Chakraborty D, Straub JE, Thirumalai D. Differences in the free energies between the excited states of Aβ40 and Aβ42 monomers encode their aggregation propensities. Proc Natl Acad Sci U S A. 2020,117 : 19926-19937.
19. Granata D, Baftizadeh F, Habchi J, Galvagnion C, De Simone A, Camilloni C, Laio A, Vendruscolo M. The inverted free energy landscape of an intrinsically disordered peptide by simulations and experiments.Sci Rep. 2015, 5 : 15449.
20. Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, Grubmüller H, MacKerell AD Jr. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017,14 : 71-73.
21. Lin YS, Bowman GR, Beauchamp KA, Pande VS. Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer. Biophys J. 2012, 102: 315-324.
22. Ball KA, Phillips AH, Nerenberg PS, Fawzi NL, Wemmer DE, Head-Gordon T. Homogeneous and heterogeneous tertiary structure ensembles of amyloid-β peptides. Biochemistry. 2011, 50 : 7612-7628.
23. Bhattacharya S, Xu L, Thompson D. Long-range regulation of partially folded amyloidogenic peptides. Sci Rep. 2020, 10 : 7597.
24. Zheng W, Tsai MY, Chen M, Wolynes PG. Exploring the aggregation free energy landscape of the amyloid-β protein (1-40). Proc Natl Acad Sci U S A. 2016, 113 : 11835-11840.
25. Bhowmik D, MacLaughlin CM, Chandrakesan M, Ramesh P, Venkatramani R, Walker GC, Maiti S. pH changes the aggregation propensity of amyloid-β without altering the monomer conformation. Phys Chem Chem Phys.2014, 16 : 885-889.
26. Vivekanandan S, Brender JR, Lee SY, Ramamoorthy A. A partially folded structure of amyloid-beta(1-40) in an aqueous environment.Biochem Biophys Res Commun. 2011, 411 : 312-316.
27. Nguyen PH, Derreumaux P. Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations. Biophys Chem. 2020, 264 : 106421.
28. Zheng W, Tsai MY, Wolynes PG. Comparing the aggregation free energy landscapes of amyloid beta(1-42) and amyloid beta(1-40). J Am Chem Soc. 2017, 139 : 16666-16676.
29. Zhang Y, Zhu Y, Yue H, Zhao Q, Li H. Exploring the misfolding and self-assembly mechanism of TTR (105-115) peptides by all-atom molecular dynamics simulation. Front Mol Biosci. 2022, 9 : 982276.
30. Liu X, Ganguly P, Jin Y, Jhatro MJ, Shea JE, Buratto SK, Bowers MT. Tachykinin neuropeptides and Amyloid β (25-35) assembly: friend or foe?J Am Chem Soc. 2022, 144 : 14614-14626.
31. Matthes D, Gapsys V, Daebel V, de Groot BL. Mapping the conformational dynamics and pathways of spontaneous steric zipper Peptide oligomerization. PLoS One. 2011, 6 : e19129.
32. He H, Liu Y, Sun Y, Ding F. Misfolding and self-assembly dynamics of microtubule-binding repeats of the Alzheimer-related protein tau.J Chem Inf Model. 2021, 61 : 2916-2925.
33. Man VH, He X, Gao J, Wang J. Effects of all-atom molecular mechanics force fields on amyloid peptide assembly: The case of PHF6 peptide of tau protein. J Chem Theory Comput. 2021, 17 : 6458-6471.
34. Chiricotto, M.; Melchionna, S.; Derreumaux, P.; Sterpone, F. Multiscale Aggregation of the Amyloid Aβ16-22 Peptide: From Disordered Coagulation and Lateral Branching to Amorphous Prefibrils. J Phys Chem Lett. 2019, 10 : 1594-1599.
35. Baftizadeh F, Biarnes X, Pietrucci F, Affinito F, Laio A. Multidimensional view of amyloid fibril nucleation in atomistic detail.J Am Chem Soc. 2012, 134 : 3886-3894.
36. Nguyen PH, Sterpone F, Derreumaux P. Self-assembly of Amyloid-beta (Aβ) peptides from solution to near in vivo  conditions. J Phys Chem B. 2022 doi: 10.1021/acs.jpcb.2c06375.
37. Klimov DK, Thirumalai D. Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure. 2003,11 : 295-307
38. Santini S, Wei G, Mousseau N, Derreumaux P. Pathway complexity of Alzheimer’s beta-amyloid Abeta16-22 peptide assembly. Structure.2004, 12 : 1245-1255.
39. Santini S, Mousseau N, Derreumaux P. In silico assembly of Alzheimer’s Abeta16-22 peptide into beta-sheets. J Am Chem Soc.2004, 126 : 11509-11516.
40. Irbäck A, Wessén J. Thermodynamics of amyloid formation and the role of intersheet interactions. J Chem Phys. 2015, 143 : 105104.
41. Li MS, Co NT, Reddy G, Hu C-K, Straub, JE, Thirumalai D. Factors governing fibrillogenesis of polypeptide chains revealed by lattice models. Phys. Rev. Lett. 2010, 105 : 218101.
42. Abeln S, Vendruscolo M, Dobson CM, Frenkel D. A Simple lattice model that captures protein folding, aggregation and amyloid formation.PLoS One. 2014, 9 : e85185.
43. Bellesia G, Shea JE. Diversity of kinetic pathways in amyloid fibril formation. J Chem Phys. 2009, 131 : 111102.
44. Šarić A, Chebaro YC, Knowles TP, Frenkel D. Crucial role of nonspecific interactions in amyloid nucleation. Proc Natl Acad Sci U S A. 2014, 111 : 17869-17874.
45. Chatterjee S, Nam Y, Salimi A, Lee JY. Monitoring early-stage β-amyloid dimer aggregation by histidine site-specific two-dimensional infrared spectroscopy in a simulation study. Phys Chem Chem Phys.2022, 24 : 18691-18702.
46. Man VH, Nguyen PH, Derreumaux P. High-resolution structures of the amyloid-β 1-42 dimers from the comparison of four atomistic force fields. J Phys Chem B. 2017, 121 : 5977-5987.
47. Itoh SG, Yagi-Utsumi M, Kato K, Okumura H. Key Residue for Aggregation of Amyloid-β Peptides. ACS Chem Neurosci. 2022,13 : 3139-3151.
48. Sun Y, Kakinen A, Wan X, Moriarty N, Hunt CPJ, Li Y, Andrikopoulos N, Nandakumar A, Davis TP, Parish CL, Song Y, Ke PC, Ding F. Spontaneous formation of β-sheet nano-barrels during the early aggregation of Alzheimer’s amyloid Beta. Nano Today. 2021, 38 : 101125.
49. Kłoniecki M, Jabłonowska A, Poznański J, Langridge J, Hughes C, Campuzano I, Giles K, Dadlez M. Ion mobility separation coupled with MS detects two structural states of Alzheimer’s disease Aβ1-40 peptide oligomers. J Mol Biol. 2011, 407 : 110-124.
50. Nguyen HL, Linh HQ, Matteini P, La Penna G, Li, MS. Emergence of barrel motif in amyloid-β trimer: A computational study. J Phys Chem B. 2020, 124: 10617-10631.
51. Nguyen PH, Campanera JM, Ngo ST, Loquet A, Derreumaux P. Tetrameric Aβ40 and Aβ42 β-barrel structures by extensive atomistic simulations. II. In aqueous solution. J Phys Chem B. 2019, 123 : 6750-6756.
52. Lendel C, Bjerring M, Dubnovitsky A, Kelly RT, Filippov A, Antzutkin ON, Nielsen NC, Härd T. A hexameric peptide barrel as building block of amyloid-β protofibrils. Angew Chem Int Ed Engl. 2014,53 : 12756-12760.
53. Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022, 19 : 679-682.
54. Santuz H, Nguyen PH, Sterpone F, Derreumaux P. Small oligomers of Aβ42 protein in the bulk solution with AlphaFold2. ACS Chem Neurosci. 2022, 13 : 711-713.
55. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A., et al. Highly accurate protein structure prediction with AlphaFold. Nature.2021, 596 : 583-589.
56. Hegedűs T, Geisler M, Lukács GL, Farkas B. Ins and outs of AlphaFold2 transmembrane protein structure predictions. Cell Mol Life Sci. 2022, 79 : 73.
57. Wong F, Krishnan A, Zheng EJ, Stärk H, Manson AL, Earl AM, Jaakkola T, Collins JJ. Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery. Mol Syst Biol. 2022,18 : e11081.
58. Martin J. When Alphafold2 predictions go wrong for protein-protein complexes, is there something to be learnt? Q Rev Biophys. 2022,55 : e6.
59. Stein RA, Mchaourab HS. SPEACH_AF: Sampling protein ensembles and conformational heterogeneity with Alphafold2. PLoS Comput Biol.2022, 18 : e1010483.
60. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000, 28 : 235-242.
61. Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol. 2001, 312: 1103-1119.
62. Fezoui Y, Teplow DB. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem. 2002, 277 : 36948-36954.
63. Lin Y, Sahoo BR, Ozawa D, Kinoshita M, Kang J, Lim MH, Okumura M, Huh YH, Moon E, Jang JH. et al. Diverse structural conversion and aggregation pathways of Alzheimer’s amyloid-β (1-40). ACS Nano.2019, 13 : 8766-8783.
64. Dammers C, Reiss K, Gremer L, Lecher J, Ziehm T, Stoldt M, Schwarten M, Willbold D. Pyroglutamate-modified amyloid-β(3-42) shows α-helical intermediates before amyloid formation. Biophys J. 2017,112 : 1621-1633.
65. Jayaraman M, Kodali R, Sahoo B, Thakur AK, Mayasundari A, Mishra R, Peterson CB, Wetzel R. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol. 2012, 415 : 881-899.
66. Mishra R, Jayaraman M, Roland BP, Landrum E, Fullam T, Kodali R, Thakur AK, Arduini I, Wetzel R. Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting α-helix-rich oligomeric intermediates. J Mol Biol. 2012, 415 : 900-917.
67. Sun Y, Kakinen A, Xing Y, Faridi P, Nandakumar A, Purcell AW, Davis TP, Ke PC, Ding F. Amyloid self-assembly of hIAPP8-20 via the accumulation of helical oligomers, α-Helix to β-sheet transition, and formation of β-barrel intermediates. Small. 2019, 15 : e1805166.
68. Misra P, Kodali R, Chemuru S, Kar K, Wetzel, R. Rapid α-oligomer formation mediated by the Aβ C terminus initiates an amyloid assembly pathway. Nat Commun. 2016, 7 : 12419.
69. Ruggeri FS, Longo G, Faggiano S, Lipiec E, Pastore A, Dietler G. Infrared nanospectroscopy characterization of oligomeric and fibrillar aggregates during amyloid formation. Nat Commun. 2015,6 : 7831.
70. Sun X, Lai L. Protein fibrils formed by rationally designed α-helical peptides. Langmuir . 2020, 36 : 6126-6131.
71. Hauser CA, Deng R, Mishra A, Loo Y, Khoe U, Zhuang F, Cheong DW, Accardo A, Sullivan MB et al. Natural tri- to hexapeptides self-assemble in water to amyloid beta-type fiber aggregates by unexpected alpha-helical intermediate structures. Proc Natl Acad Sci U S A.2011, 108 : 1361-1366.
72. Abedini A, Cao P, Raleigh DP. Detection of helical intermediates during amyloid formation by intrinsically disordered polypeptides and proteins. Methods Mol Biol. 2016, 1345 : 55-66.
73. Kim B, Do TD, Hayden EY, Teplow DB, Bowers MT, Shea JE. Aggregation of chameleon peptides: Implications of α-helicity in fibril formation.J Phys Chem B. 2016, 120 : 5874-5883.
74. Jiang Y, Jiang X, Shi X, Yang F, Cao Y, Qin X, Hou Z, Xie M, Liu N, Fang Q, Yin F, Han W, Li Z. α-Helical motif as inhibitors of toxic amyloid-β oligomer generation via highly specific recognition of amyloid surface. iScience. 2019, 17 : 87-100.
75. Kaffy J, Berardet C, Mathieu L, Legrand B, Taverna M, Halgand F, Van Der Rest G, Maillard LT, Ongeri S. Helical γ-Peptide Foldamers as Dual Inhibitors of Amyloid-β Peptide and Islet Amyloid Polypeptide Oligomerization and Fibrillization. Chemistry. 2020, 26 : 14612-14622.
76. Kumar S, Hamilton AD. α-Helix mimetics as modulators of Aβ self-assembly. J Am Chem Soc. 2017, 139 : 5744-5755.
77. Zheng X, Wu C, Liu D, Li H, Bitan G, Shea JE, Bowers MT. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?J Phys Chem B. 2016, 120 : 1615-1623.
78. Ghosh S, Verma S. Carvedilol inhibits Aβ25-35fibrillation by intervening the early stage helical intermediate formation: A biophysical investigation. Int J Biol Macromol.2021, 188 : 263-271.
79. Nguyen PH, Sterpone F, Campanera JM, Nasica-Labouze J, Derreumaux P. Impact of the A2V mutation on the heterozygous and homozygous Aβ1-40 dimer structures from atomistic simulations. ACS Chem Neurosci.2016, 7 : 823-832.
80. Sonar K, Mancera RL. Characterization of the conformations of amyloid beta 42 in solution that may mediate its initial hydrophobic aggregation. J Phys Chem B. 2022, 126 : 7916-7933.
81. Tempra C, La Rosa C, Lolicato F. The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins. Chem Phys Lipids. 2021, 236 : 105061.
82. Fu Z, Van Nostrand WE, Smith SO. Anti-parallel β-hairpin structure in soluble Aβ oligomers of Aβ40-dutch and Aβ40-iowa. Int J Mol Sci. 2021, 22 : 1225.
83. Doig AJ, Del Castillo-Frias MP, Berthoumieu O, Tarus B, Nasica-Labouze J, Sterpone F, Nguyen PH, Hooper NM, Faller P, Derreumaux P. Why is research on amyloid-β failing to give new drugs for Alzheimer’s disease? ACS Chem Neurosci. 2017, 8 : 1435-1437.
84. Doig AJ, Derreumaux P. Inhibition of protein aggregation and amyloid formation by small molecules. Curr Opin Struct Biol. 2015,30 : 50-56.